Target intelligence / Profile preview

Tetracycline efflux protein Tet(A) and Tet(B) (TetA/TetB)

Target
TetA/TetB
Molecular classification
Transporter, Major Facilitator Superfamily (MFS)
01

Overview

TetA and TetB are integral membrane proteins belonging to the Major Facilitator Superfamily (MFS) that serve as primary mediators of tetracycline resistance in Gram-negative bacteria (UniProt P02980, P02981). These pumps function as metal-tetracycline/H+ antiporters, actively extruding tetracycline-metal complexes from the cell using the energy derived from the proton-motive force (Grossman, 2016; PMC4811540). The expression of these pumps is tightly controlled by the TetR repressor protein, which ensures that the energy-intensive pumps are only produced when the antibiotic is present in the environment (Hillen & Berens, 1994; PMID 7942675). TetA and TetB are frequently encoded on mobile genetic elements like plasmids and transposons (e.g., Tn10 for TetB), facilitating their rapid spread among clinical pathogens such as Escherichia coli and Acinetobacter baumannii (CARD ARO:3000166). While they effectively confer resistance to first- and second-generation tetracyclines like doxycycline, newer agents such as tigecycline and eravacycline have been engineered to bypass these efflux mechanisms (Grossman, 2016). Consequently, these pumps are significant targets for the development of efflux pump inhibitors (EPIs) intended to restore the efficacy of traditional tetracycline therapies (MDPI, 2023; PMC10385855).

Other names
Tet(A)Tet(B)Tetracycline resistance protein class ATetracycline resistance protein class BMetal-tetracycline/H+ antiporterTetracycline efflux pumptetA/tetB resistance machinery
02

Mechanism of action

The TetA and TetB pumps function as energy-dependent efflux systems that export tetracycline-divalent metal complexes (e.g., [Mg-tetracycline]+) from the bacterial cytoplasm in exchange for a proton (H+), utilizing the proton-motive force (Grossman, 2016; PMC4811540). This process is regulated by the TetR repressor, which binds to the operator region in the absence of the drug; upon binding tetracycline, TetR undergoes a conformational change and dissociates, allowing the transcription of the efflux pump genes (Hillen & Berens, 1994; PMID 7942675).

03

Biological functions

Antibiotic effluxAntimicrobial resistanceIon transportProton-motive force utilization
04

Disease associations

Bacterial infectionAntimicrobial resistance (AMR)Nosocomial infection
05

Safety considerations

Rapid dissemination via horizontal gene transfer (HGT) (CARD ARO:3000166)Development of multi-drug resistance (MDR) through pump overexpression (MDPI, 2023)Potential toxicity of non-specific efflux pump inhibitors in host cellsEvasion by newer generation tetracyclines like tigecycline (Grossman, 2016)
06

Interacting drugs

Tetracycline

7 more in the full profile.

07

Biomarkers

Detection of tetA or tetB genes via PCR or NGS (CARD ARO:3000166)Minimum Inhibitory Concentration (MIC) values for tetracyclines (Grossman, 2016)Reduction in MIC upon addition of efflux pump inhibitors like CCCP (MDPI, 2023; PMC10385855)

Beyond the preview

Go deeper on Tetracycline efflux protein Tet(A) and Tet(B) (TetA/TetB).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tetracycline efflux protein Tet(A) and Tet(B) (TetA/TetB).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call